Tomas Kiselak
Director at Viridian Therapeutics, Inc.\DE (VRDN)
Tomas Kiselak has filed 6 insider reports with the SEC since February 2021, as director at Viridian Therapeutics, Inc.\DE (VRDN). The latest filing, on July 2, 2026, reports grant or award at Viridian Therapeutics, Inc.\DE (VRDN).
- Filings
- 6
- Companies
- 1
- Bought on market
- None
- Sold on market
- None
Companies where Tomas Kiselak is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | $30.12 | Jul 2, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jul 1, 2026VRDNSEC Form 4 filed by Director Kiselak TomasForm 4Grant or award
- Jul 1, 2025VRDNSEC Form 4 filed by Director Kiselak TomasForm 4Grant or award
- Jun 14, 2023VRDNSEC Form 4 filed by Kiselak TomasForm 4Grant or award
- Jun 8, 2022VRDNSEC Form 4 filed by Kiselak TomasForm 4Grant or award
- Jun 3, 2021VRDNSEC Form 4 filed by Kiselak TomasForm 4Grant or award
- Feb 4, 2021VRDNSEC Form 4 filed by Tomas KiselakForm 4Grant or award
Compare Tomas Kiselak with
- Tomas Kiselak vs Jennifer Tousignant1 shared
- Tomas Kiselak vs Radhika Tripuraneni1 shared
- Tomas Kiselak vs Arlene Morris1 shared
- Tomas Kiselak vs Sarah Gheuens1 shared
- Tomas Kiselak vs Jeffrey Robert Ajer1 shared
- Tomas Kiselak vs Jennifer K. Moses1 shared
Other insiders at the same companies
- Jennifer TousignantVRDN
- Radhika TripuraneniVRDN
- Sarah GheuensVRDN
- Arlene MorrisVRDN
- Christopher W. CainVRDN
- Jeffrey Robert AjerVRDN
- Jennifer K. MosesVRDN
- Fairmount Funds Management LLCVRDN
- Seth HarmonVRDN
- Thomas W. BeethamVRDN
- Stephen F. MahoneyVRDN
Questions about Tomas Kiselak
- What is Tomas Kiselak's role at Viridian Therapeutics, Inc.\DE?
- Tomas Kiselak reports to the SEC as director at Viridian Therapeutics, Inc.\DE (VRDN), according to the latest filing on July 2, 2026.
- Has Tomas Kiselak bought or sold stock recently?
- No open-market purchases or sales by Tomas Kiselak are on file. The filings report grant or award.
- How do I get alerts when Tomas Kiselak files?
- Follow Tomas Kiselak on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Tomas Kiselak (SEC CIK 0001830177). Totals count each trade once, skipping amendments whose original is on file, from Feb 8, 2021 on. View on SEC EDGAR